Job for Pharma Professionals at HLL Lifecare Limited

HLL Lifecare Limited is a Govt. of India Healthcare products manufacturing and services Company based in Thiruvananthapuram, Kerala, India under the Union Ministry of Health and Family Welfare, HLL is a global leader in the area of contraceptives, hospital products and healthcare services.

With 7 manufacturing units, 7 subsidiary companies, 22 regional offices and having presence in more than 115 countries, HLL is positioned as a total healthcare solution provider catering to the well-being of the society at large.

Post :SCIENTIST E3

Job Description
The job profile for the position is as under:
1. Development of drug delivery systems/ implants for regulated markets

2. Preparation of dossier for regulatory submissions for obtaining marketing clearance in regulated markets

3. Scale up and Technology Transfer

4. Meeting audit as per regulatory requirements

Candidate Profile

Maximum Age: 40 years as on 01.05.2021
Consolidated pay range (For Fixed Term Contract engagement): 35,000 –65,000/- (Senior Manager (E3) per month.

(The consolidated pay will be fixed within the pay range depending on the qualification, experience and the current pay drawn by the candidate. The consolidated pay will be inclusive of all allowances and benefits).

Educational Qualification:

Essential: PhD in Pharmaceutics / M.Pharm Pharmaceutics

Essential: Minimum 5 years post qualification for PhD/ Minimum 8 Years post qualification experience for M.Pharm
Desirable: Patents, Technology transfers in novel drug delivery systems

General Conditions:
• SC/ST/OBC/PwD candidates will be eligible for relaxation as per Government of India directives.
• Canvassing in any form will be a disqualification.
Location :  Anywhere in India
Last Date : 26.05.2021

Related Posts

DCGI Cracks Down On 90 Unapproved Fixed-Dose Combinations: Cough Syrups, Vitamins, Diabetes Drugs Among Those Flagged For Sale Without Central Approval

New Delhi — India’s top drug regulator has issued a nationwide alert over 90 fixed-dose combination (FDC) drugs being manufactured and sold without mandatory central approval, directing all state and…

India’s drug body flags 90 unapproved FDC medicines, states told to take action

The Central Drugs Standard Control Organisation (CDSCO), India’s top drug regulator, has identified at least 90 unapproved fixed-dose combination (FDC) medicines in circulation and asked states to move against those…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Ship of Domestic Medical Device Industry flounders, thanks to Israel-Iran War

Ship of Domestic Medical Device Industry flounders, thanks to Israel-Iran War

DCGI Cracks Down On 90 Unapproved Fixed-Dose Combinations: Cough Syrups, Vitamins, Diabetes Drugs Among Those Flagged For Sale Without Central Approval

DCGI Cracks Down On 90 Unapproved Fixed-Dose Combinations: Cough Syrups, Vitamins, Diabetes Drugs Among Those Flagged For Sale Without Central Approval

India’s drug body flags 90 unapproved FDC medicines, states told to take action

India’s drug body flags 90 unapproved FDC medicines, states told to take action

India advancing as a global hub of affordable, quality healthcare solutions: Dr Jitendra Singh

India advancing as a global hub of affordable, quality healthcare solutions: Dr Jitendra Singh

Unapproved drops for dry eyes pose risks: Govt

Unapproved drops for dry eyes pose risks: Govt

Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?

Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?